CleavPredict: A platform for reasoning about matrix metalloproteinases proteolytic events

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Kumar, Sonu ^a   Ratnikov, Boris I ^a   Kazanov, Marat D ^b   Smith, Jeffrey W ^a   Cieplak, Piotr Cieplak ^a  

^a BURNHAM INSTITUTE   (United States)

^b INSTITUTE FOR INFORMATION TRANSMISSION PROBLEMS   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; MATRILYSIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 15; MATRIX METALLOPROTEINASE 16; MATRIX METALLOPROTEINASE 17; MATRIX METALLOPROTEINASE 26; STROMELYSIN; STROMELYSIN 2;

ACCURACY; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CLIENT SERVER APPLICATION; COMPUTER PROGRAM; GENE EXPRESSION; HIGH THROUGHPUT SCREENING; HUMAN; MASS SPECTROMETRY; PHAGE DISPLAY; PREDICTION; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN SECONDARY STRUCTURE; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM; ALGORITHM; GENETIC DATABASE; METABOLISM; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; SOFTWARE; WEB BROWSER;

ALGORITHMS; DATABASES, GENETIC; MATRIX METALLOPROTEINASES; PROTEOLYSIS; REPRODUCIBILITY OF RESULTS; ROC CURVE; SOFTWARE; WEB BROWSER;

EID: 84930662404     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0127877     Document Type: Article

References (83)

1. Lopez-Otin C, Bond JS. Proteases: multifunctional enzymes in life and disease. J Biol Chem. 2008; 283(45):30433-7. Epub 2008/07/25. doi: 10.1074/jbc.R800035200 PMID: 18650443; PubMed Central PMCID: PMC2576539.
2. Belushkin AA, Vinogradov DV, Gelfand MS, Osterman AL, Cieplak P, Kazanov MD. Sequence-derived structural features driving proteolytic processing. Proteomics. 2014; 14(1):42-50. Epub 2013/11/15. doi: 10.1002/pmic.201300416 PMID: 24227478.
3. Igarashi Y, Eroshkin A, Gramatikova S, Gramatikoff K, Zhang Y, Smith JW, et al. CutDB: a proteolytic event database. Nucleic acids research. 2007; 35(Database issue):D546-9. Epub 2006/12/05. doi: 10.1093/nar/gkl813 PMID: 17142225; PubMed Central PMCID: PMC1669773.
4. Lopez-Aviles S, Uhlmann F. Cell cycle: the art of multi-tasking. Current biology: CB. 2010; 20(3):R101-3. Epub 2010/02/11. doi: 10.1016/j.cub.2010.01.001 PMID: 20144767.
5. Churg A, Zhou S, Wright JL. Series "matrix metalloproteinases in lung health and disease": Matrix metalloproteinases in COPD. The European respiratory journal: official journal of the European Society for Clinical Respiratory Physiology. 2012; 39(1):197-209. Epub 2011/09/17. doi: 10.1183/09031936.00121611 PMID: 21920892.
6. Critchley DR. Smurf1 zaps the talin head. Nature cell biology. 2009; 11(5):538-40. Epub 2009/05/01. doi: 10.1038/ncb0509-538 PMID: 19404335.
7. Page-McCaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol. 2007; 8(3):221-33. PMID: 17318226.
8. Brown MS, Goldstein JL. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell. 1997; 89(3):331-40. PMID: 9150132.
9. Coughlin SR. Thrombin signalling and protease-activated receptors. Nature. 2000; 407(6801):258-64. PMID: 11001069.
10. Salvesen GS, Dixit VM. Caspases: intracellular signaling by proteolysis. Cell. 1997; 91(4):443-6. Epub 1997/12/09. PMID: 9390553.
11. Overall CM, Kleifeld O. Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nature reviews Cancer. 2006; 6(3):227-39. Epub 2006/02/25. doi: 10.1038/nrc1821 PMID: 16498445.
12. Carrell RW, Owen MC. Plakalbumin, alpha 1-antitrypsin, antithrombin and the mechanism of inflammatory thrombosis. Nature. 1985; 317(6039):730-2. PMID: 3877243.
13. Holmbeck K, Bianco P, Caterina J, Yamada S, Kromer M, Kuznetsov SA, et al. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell. 1999; 99(1):81-92. PMID: 10520996.
14. Haass C, De Strooper B. The presenilins in Alzheimer's disease - proteolysis holds the key. Science. 1999; 286(5441):916-9. PMID: 10542139.
15. Wuarin J, Nurse P. Regulating S phase: CDKs, licensing and proteolysis. Cell. 1996; 85(6):785-7. PMID: 8681373.
16. Buller RM, Palumbo GJ. Poxvirus pathogenesis. Microbiol Rev. 1991; 55(1):80-122. PMID: 1851533.
17. Rossetto O, de Bernard M, Pellizzari R, Vitale G, Caccin P, Schiavo G, et al. Bacterial toxins with intracellular protease activity. Clin Chim Acta. 2000; 291(2):189-99. PMID: 10675723.
18. Lorenz IC, Marcotrigiano J, Dentzer TG, Rice CM. Structure of the catalytic domain of the hepatitis C virus NS2-3 protease. Nature. 2006; 442(7104):831-5. PMID: 16862121.
19. Coussens LM, Fingleton B, Matrisian LM. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science. 2002; 295(5564):2387-92. Epub 2002/03/30. doi: 10.1126/science.1067100 PMID: 11923519.
20. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002; 2(3):161-74. PMID: 11990853.
21. Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 2010; 141(1):52-67. Epub 2010/04/08. doi: 10.1016/j.cell.2010.03.015 PMID: 20371345; PubMed Central PMCID: PMC2862057.
22. Page-McCaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nature reviews Molecular cell biology. 2007; 8(3):221-33. PMID: 17318226.
23. Dziembowska M, Wlodarczyk J. MMP9: a novel function in synaptic plasticity. The international journal of biochemistry & cell biology. 2012; 44(5):709-13. Epub 2012/02/14. doi: 10.1016/j.biocel.2012.01.023 PMID: 22326910.
24. Troeberg L, Nagase H. Proteases involved in cartilage matrix degradation in osteoarthritis. Biochimica et biophysica acta. 2012; 1824(1):133-45. Epub 2011/07/23. doi: 10.1016/j.bbapap.2011.06.020 PMID: 21777704; PubMed Central PMCID: PMC3219800.
25. Burrage PS, Mix KS, Brinckerhoff CE. Matrix metalloproteinases: role in arthritis. Frontiers in bioscience: a journal and virtual library. 2006; 11:529-43. Epub 2005/09/09. PMID: 16146751.
26. Hwang IK, Park SM, Kim SY, Lee ST. A proteomic approach to identify substrates of matrix metalloproteinase-14 in human plasma. Biochimica et biophysica acta. 2004; 1702(1):79-87. PMID: 15450852.
27. Vanlaere I, Libert C. Matrix metalloproteinases as drug targets in infections caused by gram-negative bacteria and in septic shock. Clinical microbiology reviews. 2009; 22(2):224-39, Table of Contents. Epub 2009/04/16. doi: 10.1128/CMR.00047-08 PMID: 19366913; PubMed Central PMCID: PMC2668236.
28. Murphy G, Nagase H. Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: destruction or repair? Nat Clin Pract Rheumatol. 2008; 4(3):128-35. Epub 2008/02/07. ncprheum0727 [pii] doi: 10.1038/ncprheum0727 PMID: 18253109.
29. Wu W, Billinghurst RC, Pidoux I, Antoniou J, Zukor D, Tanzer M, et al. Sites of collagenase cleavage and denaturation of type II collagen in aging and osteoarthritic articular cartilage and their relationship to the distribution of matrix metalloproteinase 1 and matrix metalloproteinase 13. Arthritis Rheum. 2002; 46(8):2087-94. Epub 2002/09/05. doi: 10.1002/art.10428 PMID: 12209513.
30. Fraser A, Fearon U, Billinghurst RC, Ionescu M, Reece R, Barwick T, et al. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation. Arthritis Rheum. 2003; 48(11):3085-95. Epub 2003/11/13. doi: 10.1002/art.11331 PMID: 14613270.
31. Lark MW, Bayne EK, Flanagan J, Harper CF, Hoerrner LA, Hutchinson NI, et al. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints. J Clin Invest. 1997; 100(1):93-106. Epub 1997/07/01. doi: 10.1172/JCI119526 PMID: 9202061; PubMed Central PMCID: PMC508169.
32. Andersen TL, del Carmen Ovejero M, Kirkegaard T, Lenhard T, Foged NT, Delaisse JM. A scrutiny of matrix metalloproteinases in osteoclasts: evidence for heterogeneity and for the presence of MMPs synthesized by other cells. Bone. 2004; 35(5):1107-19. Epub 2004/11/16. S8756-3282(04)00261-3 [pii] doi: 10.1016/j.bone.2004.06.019 PMID: 15542036.
33. Benito MJ, Veale DJ, FitzGerald O, van den Berg WB, Bresnihan B. Synovial tissue inflammation in early and late osteoarthritis. Ann Rheum Dis. 2005; 64(9):1263-7. Epub 2005/02/26. ard.2004.025270 [pii] doi: 10.1136/ard.2004.025270 PMID: 15731292; PubMed Central PMCID: PMC1755629.
34. Zhou Z, Apte SS, Soininen R, Cao R, Baaklini GY, Rauser RW, et al. Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc Natl Acad Sci U S A. 2000; 97(8):4052-7. Epub 2000/03/29. doi: 10.1073/pnas.060037197060037197 [pii]. PMID: 10737763; PubMed Central PMCID: PMC18145.
35. Kato T, Kure T, Chang JH, Gabison EE, Itoh T, Itohara S, et al. Diminished corneal angiogenesis in gelatinase A-deficient mice. FEBS Lett. 2001; 508(2):187-90. Epub 2001/11/24. S0014-5793(01)02897-6 [pii]. PMID: 11718713.
36. Lambert V, Wielockx B, Munaut C, Galopin C, Jost M, Itoh T, et al. MMP-2 and MMP-9 synergize in promoting choroidal neovascularization. FASEB J. 2003; 17(15):2290-2. Epub 2003/10/18. doi: 10.1096/fj.03-0113fje 03-0113fje [pii]. PMID: 14563686.
37. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1996; 86(3):353-64. Epub 1996/08/09. S0092-8674(00)80108-7 [pii]. PMID: 8756718.
38. Rodriguez-Manzaneque JC, Lane TF, Ortega MA, Hynes RO, Lawler J, Iruela-Arispe ML. Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor. Proc Natl Acad Sci U S A. 2001; 98(22):12485-90. Epub 2001/10/19. doi: 10.1073/pnas.171460498171460498 [pii]. PMID: 11606713; PubMed Central PMCID: PMC60080.
39. Oh J, Takahashi R, Kondo S, Mizoguchi A, Adachi E, Sasahara RM, et al. The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell. 2001; 107(6):789-800. Epub 2001/12/19. S0092-8674(01)00597-9 [pii]. PMID: 11747814.
40. Martin DC, Sanchez-Sweatman OH, Ho AT, Inderdeo DS, Tsao MS, Khokha R. Transgenic TIMP-1 inhibits simian virus 40 T antigen-induced hepatocarcinogenesis by impairment of hepatocellular proliferation and tumor angiogenesis. Lab Invest. 1999; 79(2):225-34. Epub 1999/03/06. PMID: 10068210.
41. Li H, Lindenmeyer F, Grenet C, Opolon P, Menashi S, Soria C, et al. AdTIMP-2 inhibits tumor growth, angiogenesis, and metastasis, and prolongs survival in mice. Hum Gene Ther. 2001; 12(5):515-26. Epub 2001/03/27. doi: 10.1089/104303401300042429 PMID: 11268284.
42. Gatto C, Rieppi M, Borsotti P, Innocenti S, Ceruti R, Drudis T, et al. BAY 12-9566, a novel inhibitor of matrix metalloproteinases with antiangiogenic activity. Clin Cancer Res. 1999; 5(11):3603-7. Epub 1999/12/10. PMID: 10589777.
43. Newby AC. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev. 2005; 85(1):1-31. Epub 2004/12/25. 85/1/1 [pii] doi: 10.1152/physrev.00048.2003 PMID: 15618476.
44. Newby AC. Metalloproteinases and vulnerable atherosclerotic plaques. Trends Cardiovasc Med. 2007; 17(8):253-8. Epub 2007/11/21. S1050-1738(07)00178-8 [pii] doi: 10.1016/j.tcm.2007.09.001 PMID: 18021934.
45. Shipley JM, Wesselschmidt RL, Kobayashi DK, Ley TJ, Shapiro SD. Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice. Proc Natl Acad Sci U S A. 1996; 93(9):3942-6. Epub 1996/04/30. PMID: 8632994; PubMed Central PMCID: PMC39464.
46. Johnson JL, Baker AH, Oka K, Chan L, Newby AC, Jackson CL, et al. Suppression of atherosclerotic plaque progression and instability by tissue inhibitor of metalloproteinase-2: involvement of macrophage migration and apoptosis. Circulation. 2006; 113(20):2435-44. Epub 2006/05/17. CIRCULATIONAHA.106.613281 [pii] doi: 10.1161/CIRCULATIONAHA.106.613281 PMID: 16702468.
47. Johnson JL, Fritsche-Danielson R, Behrendt M, Westin-Eriksson A, Wennbo H, Herslof M, et al. Effect of broad-spectrum matrix metalloproteinase inhibition on atherosclerotic plaque stability. Cardiovasc Res. 2006; 71(3):586-95. Epub 2006/06/09. S0008-6363(06)00192-1 [pii] doi: 10.1016/j.cardiores.2006.05.009 PMID: 16759648.
48. Pepper MS. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol. 2001; 21(7):1104-17. Epub 2001/07/14. PMID: 11451738.
49. Newby AC. Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates. Cardiovasc Res. 2006; 69(3):614-24. Epub 2005/11/04. S0008-6363(05)00407-4 [pii] doi: 10.1016/j.cardiores.2005.08.002 PMID: 16266693.
50. Butler GS, Overall CM. Proteomic identification of multitasking proteins in unexpected locations complicates drug targeting. Nat Rev Drug Discov. 2009; 8(12):935-48. Epub 2009/12/02. doi: 10.1038/nrd2945 PMID: 19949400.
51. Butler GS, Overall CM. Updated biological roles for matrix metalloproteinases and new "intracellular"substrates revealed by degradomics. Biochemistry. 2009; 48(46):10830-45. Epub 2009/10/13. doi: 10.1021/bi901656f PMID: 19817485.
52. Ratnikov B, Cieplak P, Smith JW. High throughput substrate phage display for protease profiling. Methods Mol Biol. 2009; 539:93-114. Epub 2009/04/21. doi: 10.1007/978-1-60327-003-8-6 PMID: 19377968; PubMed Central PMCID: PMC3372406.
53. Ratnikov BI, Cieplak P, Gramatikoff K, Pierce J, Eroshkin A, Igarashi Y, et al. Basis for substrate recognition and distinction by matrix metalloproteinases. Proc Natl Acad Sci U S A. 2014; 111(40):E4148-55. doi: 10.1073/pnas.1406134111 PMID: 25246591.
54. Kazanov MD, Igarashi Y, Eroshkin AM, Cieplak P, Ratnikov B, Zhang Y, et al. Structural determinants of limited proteolysis. Journal of proteome research. 2011; 10(8):3642-51. Epub 2011/06/21. doi: 10.1021/pr200271w PMID: 21682278; PubMed Central PMCID: PMC3164237.
55. Hubbard SJ. The structural aspects of limited proteolysis of native proteins. Biochimica et biophysica acta. 1998; 1382(2):191-206. Epub 1998/04/16. S0167-4838(97)00175-1 [pii]. PMID: 9540791.
56. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, et al. The Protein Data Bank. Nucleic Acids Res. 2000; 28(1):235-42. PMID: 10592235.
57. Golubkov VS, Chekanov AV, Cieplak P, Aleshin AE, Chernov AV, Zhu W, et al. The Wnt/planar cell polarity protein-tyrosine kinase-7 (PTK7) is a highly efficient proteolytic target of membrane type-1 matrix metalloproteinase: implications in cancer and embryogenesis. J Biol Chem. 2010; 285(46):35740-9. Epub 2010/09/15. doi: 10.1074/jbc.M110.165159 PMID: 20837484; PubMed Central PMCID: PMC2975198.
58. Golubkov VS, Cieplak P, Chekanov AV, Ratnikov BI, Aleshin AE, Golubkova NV, et al. Internal cleavages of the autoinhibitory prodomain are required for membrane type 1 matrix metalloproteinase activation, although furin cleavage alone generates inactive proteinase. The Journal of biological chemistry. 2010; 285(36):27726-36. Epub 2010/07/08. doi: 10.1074/jbc.M110.135442 PMID: 20605791; PubMed Central PMCID: PMC2934640.
59. Shiryaev SA, Savinov AY, Cieplak P, Ratnikov BI, Motamedchaboki K, Smith JW, et al. Matrix metalloproteinase proteolysis of the myelin basic protein isoforms is a source of immunogenic peptides in autoimmune multiple sclerosis. PloS one. 2009; 4(3):e4952. Epub 2009/03/21. doi: 10.1371/journal.pone.0004952 PMID: 19300513; PubMed Central PMCID: PMC2654159.
60. Shiryaev SA, Cieplak P, Aleshin AE, Sun Q, Zhu W, Motamedchaboki K, et al. Matrix metalloproteinase proteolysis of the mycobacterial HSP65 protein as a potential source of immunogenic peptides in human tuberculosis. Febs J. 2011; 278(18):3277-86. Epub 2011/07/15. doi: 10.1111/j.1742-4658.2011.08244.x PMID: 21752195; PubMed Central PMCID: PMC3197701.
61. Shiryaev SA, Remacle AG, Savinov AY, Chernov AV, Cieplak P, Radichev IA, et al. Inflammatory proprotein convertase-matrix metalloproteinase proteolytic pathway in antigen-presenting cells as a step to autoimmune multiple sclerosis. The Journal of biological chemistry. 2009; 284(44):30615-26. Epub 2009/09/04. doi: 10.1074/jbc.M109.041244 PMID: 19726693; PubMed Central PMCID: PMC2781616.
62. Song J, Tan H, Perry AJ, Akutsu T, Webb GI, Whisstock JC, et al. PROSPER: an integrated feature-based tool for predicting protease substrate cleavage sites. PloS one. 2012; 7(11):e50300. Epub 2012/12/05. doi: 10.1371/journal.pone.0050300 PMID: 23209700; PubMed Central PMCID: PMC3510211.
63. Schechter I, Berger A. On the size of the active site in proteases. I. Papain. 1967. Biochemical and biophysical research communications. 1967; 425(3):497-502. doi: 10.1016/j.bbrc.2012.08.015 PMID: 22925665.
64. Witten IH, Frank E, Hall MA. Data Mining: Practical Machines Learning Tools and Techniques. third edition ed. Amsterdam: Elsevier; 2011. 149 p.
65. Prudova A, auf dem Keller U, Butler GS, Overall CM. Multiplex N-terminome analysis of MMP-2 and MMP-9 substrate degradomes by iTRAQ-TAILS quantitative proteomics. Molecular & cellular proteomics: MCP. 2010; 9(5):894-911. Epub 2010/03/23. doi: 10.1074/mcp.M000050-MCP201 PMID: 20305284; PubMed Central PMCID: PMC2871422.
66. Schilling O, Overall CM. Proteome-derived, database-searchable peptide libraries for identifying protease cleavage sites. Nat Biotechnol. 2008; 26(6):685-94. PMID: 18500335.
67. Cuff JA, Barton GJ. Application of multiple sequence alignment profiles to improve protein secondary structure prediction. Proteins. 2000; 40(3):502-11. Epub 2000/06/22. PMID: 10861942.
68. Ward JJ, McGuffin LJ, Bryson K, Buxton BF, Jones DT. The DISOPRED server for the prediction of protein disorder. Bioinformatics. 2004; 20(13):2138-9. Epub 2004/03/27. doi: 10.1093/bioinformatics/bth195bth195 [pii]. PMID: 15044227.
69. Joosten RP, te Beek TA, Krieger E, Hekkelman ML, Hooft RW, Schneider R, et al. A series of PDB related databases for everyday needs. Nucleic Acids Res. 2011; 39(Database issue):D411-9. Epub 2010/11/13. doi: 10.1093/nar/gkq1105 PMID: 21071423; PubMed Central PMCID: PMC3013697.
70. Kabsch W, Sander C. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers. 1983; 22(12):2577-637. Epub 1983/12/01. doi: 10.1002/bip.360221211 PMID: 6667333.
71. Petersen TN, Brunak S, von Heijne G, Nielsen H. SignalP 4.0: discriminating signal peptides from transmembrane regions. Nat Methods. 2011; 8(10):785-6. Epub 2011/10/01. doi: 10.1038/nmeth.1701 PMID: 21959131.
72. Krogh A, Larsson B, von Heijne G, Sonnhammer EL. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol. 2001; 305(3):567-80. Epub 2001/01/12. doi: 10.1006/jmbi.2000.4315 PMID: 11152613.
73. Obayashi T, Okamura Y, Ito S, Tadaka S, Motoike IN, Kinoshita K. COXPRESdb: a database of comparative gene coexpression networks of eleven species for mammals. Nucleic Acids Res. 2013; 41 (Database issue):D1014-20. Epub 2012/12/04. doi: 10.1093/nar/gks1014 PMID: 23203868; PubMed Central PMCID: PMC3531062.
74. Calderone A, Castagnoli L, Cesareni G. mentha: a resource for browsing integrated protein-interaction networks. Nat Methods. 2013; 10(8):690-1. Epub 2013/08/01. doi: 10.1038/nmeth.2561 PMID: 23900247.
75. Magrane M, Consortium U. UniProt Knowledgebase: a hub of integrated protein data. Database (Oxford). 2011; 2011:bar009. Epub 2011/03/31. doi: 10.1093/database/bar009 PMID: 21447597; PubMed Central PMCID: PMC3070428.
76. Yip YL, Scheib H, Diemand AV, Gattiker A, Famiglietti LM, Gasteiger E, et al. The Swiss-Prot variant page and the ModSNP database: a resource for sequence and structure information on human protein variants. Hum Mutat. 2004; 23(5):464-70. Epub 2004/04/27. doi: 10.1002/humu.20021 PMID: 15108278.
77. Lu CT, Huang KY, Su MG, Lee TY, Bretana NA, Chang WC, et al. DbPTM 3.0: an informative resource for investigating substrate site specificity and functional association of protein post-translational modifications. Nucleic Acids Res. 2013; 41(Database issue):D295-305. Epub 2012/11/30. doi: 10.1093/nar/gks1229 PMID: 23193290; PubMed Central PMCID: PMC3531199.
78. Martin AC. Mapping PDB chains to UniProtKB entries. Bioinformatics. 2005; 21(23):4297-301. Epub 2005/09/29. doi: 10.1093/bioinformatics/bti694 PMID: 16188924.
79. Rawlings ND, Waller M, Barrett AJ, Bateman A. MEROPS: the database of proteolytic enzymes, their substrates and inhibitors. Nucleic acids research. 2014; 42(Database issue):D503-9. Epub 2013/10/26. doi: 10.1093/nar/gkt953 PMID: 24157837.
80. Shiryaev SA, Chernov AV, Golubkov VS, Thomsen ER, Chudin E, Chee MS, et al. High-resolution analysis and functional mapping of cleavage sites and substrate proteins of furin in the human proteome. PloS one. 2013; 8(1):e54290. Epub 2013/01/22. doi: 10.1371/journal.pone.0054290 PMID: 23335997; PubMed Central PMCID: PMC3545927.
81. Shiryaev SA, Remacle AG, Chernov AV, Golubkov VS, Motamedchaboki K, Muranaka N, et al. Substrate cleavage profiling suggests a distinct function of Bacteroides fragilis metalloproteinases (fragilysin and metalloproteinase II) at the microbiome-inflammation-cancer interface. The Journal of biological chemistry. 2013; 288(48):34956-67. Epub 2013/10/23. doi: 10.1074/jbc.M113.516153 PMID: 24145028; PubMed Central PMCID: PMC3843106.
82. Shiryaev SA, Thomsen ER, Cieplak P, Chudin E, Cheltsov AV, Chee MS, et al. New details of HCV NS3/4A proteinase functionality revealed by a high-throughput cleavage assay. PloS one. 2012; 7(4): e35759. Epub 2012/05/05. doi: 10.1371/journal.pone.0035759 PMID: 22558217; PubMed Central PMCID: PMC3338790.
83. Crooks GE, Hon G, Chandonia JM, Brenner SE. WebLogo: a sequence logo generator. Genome Res. 2004; 14(6):1188-90. PMID: 15173120.